Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy

prnewswire.com
BIIB AMGN LLY JNJ PFE MRK BMY GILD REGN AZN ABBV SNY NVO LULU GOOG MSFT AMZN META TSLA NVDA XOM CVX KO PEP MCD DIS BA CAT GS JPM BAC WFC C T VZ CMCSA NFLX ADBE CRM INTC QCOM AMD CSCO HON GE IBM ORCL SAP ACN MU AMAT LRCX ADI TXN NXPI MRVL MCHP PYPL CMG SBUX NKE HD PG UNH ELV CVS CI HCA MCK CAH

Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns

globenewswire.com
APLS BLRX LLY NVO TAK

Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline

businesswire.com
LLY

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

globenewswire.com
NVDA LLY

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

globenewswire.com
NVDA LLY TMO AMGN

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study

globenewswire.com
BIIB LLY TECH

HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options

prnewswire.com
LLY

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

globenewswire.com
LLY NVO

Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients

accessnewswire.com
NVO LLY

Rejuvacare Ozempatch Ingredients Investigated: 2026 Consumer Analysis Examines Herbal Patch Formulation Disclosures

globenewswire.com
JNJ LLY